Firstly, as shown in Figure 1A, we conducted a differential analysis of CPA4 expression in pan‐cancer and discovered that CPA4 expression is high in 14 malignancies, such as Bladder urothelial carcinoma (BLCA) and KIRC (p < 0.05). Here, CPA4 is linked to bladder transitional cell carcinoma.